levodopa/carbidopa
| Uses | • Parkinson's disease |
| Contraindications, drug interactions or cautions | Contraindications • concomitant use of monoamine oxidase inhibitors (MAOIs), psychosis, narrow angle glaucoma, upper gastrointestinal bleeding Drug interactions • monoamine oxidase inhibitors (MAOIs) |
| Adverse Effects (common and severe) | • nausea • vomiting • anorexia • headache • confusion • hallucination • alopecia • insomnia • discolored urine • dyskinesia |
| Instructions and dose (initial; typical) | 50/12.5mg twice a day |
| Monitoring | • complete blood count • liver function tests • thyroid stimulating hormone • electrolytes |
| Source of Suggestion | WHO Model List of Essential Medicines (Added on August, 2015) |